封面
市场调查报告书
商品编码
1672727

组织和器官移植市场:按产品类型、按移植类型、按应用、按最终用户、按地区

Tissue and Organ Transplantation Market, By Product Type, By Type of Transplant, By Application , By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 220 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2025 年全球组织和器官移植市场规模估计为 187.5 亿美元,预计到 2032 年将达到 356.5 亿美元,2025 年至 2032 年的年复合成长率(CAGR)为 9.6%。

报告范围 报告详细信息
基准年 2024 2025 年市场规模 187.5亿美元
效能资料 2020-2024 预测期 2025-2032
预测期:2025 年至 2032 年复合年增长率 9.60% 2032 年金额预测 356.5亿美元
图。
组织与器官移植市场-IMG1

组织或器官移植是一种外科手术,将组织或器官从一个人转移到另一个人,以修復、替换或增强接受者的器官或组织。组织和器官移植已成为世界上成长最快的医学专业领域之一。组织和器官衰竭对人们的生活产生重大影响,但移植为全世界数百万患者带来了希望。由于文明病和道路事故导致的器官衰竭率不断上升,推动了全球对组织和器官移植的需求。移植技术和预防移植排斥的免疫抑制疗法的进步也推动了市场的成长。

市场动态

全球组织和器官移植市场的成长主要受到导致器官衰竭的慢性病和文明病盛行率上升的推动。此外,全球老化人口的不断增长也推动了对替代组织和器官的需求。根据世界卫生组织估计,到2050年,65岁及以上人口预计将从2010年的5.24亿增加到近15亿。此外,移植技术的进步和更有效的免疫抑制剂的开发以防止器官排斥可能会为市场相关人员提供新的机会。然而,组织和器官移植程序的高成本以及合适器官的短缺可能会阻碍市场的成长。对器官贩卖的伦理担忧和对器官捐赠的宗教禁令可能会阻碍可移植器官的供应。

研究的主要特点

  • 本报告对全球组织和器官移植市场进行了详细分析,并提供了预测期(2025-2032)的市场规模(十亿美元)和年复合成长率(CAGR%),假设 2024 年为基准年。
  • 它还强调了各个领域的潜在商机并说明了该市场的有吸引力的投资提案矩阵。
  • 它还提供了对市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。
  • 全球组织和器官移植市场的主要企业是根据公司亮点、产品系列、关键亮点、财务绩效和策略等参数进行的分析。
  • 本报告的见解将使负责人和企业经营团队能够就未来产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。
  • 全球组织和器官移植市场报告针对该行业的各个相关人员,包括投资者、供应商、产品製造商、经销商、新进入者和金融分析师。
  • 相关人员可以透过全球组织和器官移植市场分析中使用的各种策略矩阵来促进决策。

目录

第一章 调查目的与前提条件

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告描述
    • 市场定义和范围
  • 执行摘要
  • 一致的机会图 (COM)

第三章市场动态、法规与趋势分析

  • 市场动态
    • 驱动程式
    • 限制因素
    • 机会
  • 影响分析
  • 市场趋势
  • 监管情景
  • 收购和合作场景
  • 资金筹措和投资
  • PEST分析
  • 波特的分析

4. 全球组织与器官移植市场 - 冠状病毒 (COVID-19) 大流行的影响

  • 整体影响
  • 政府倡议
  • COVID-19 市场影响

5. 2020 年至 2032 年按产品类型分類的全球组织和器官移植市场(十亿美元)

  • 介绍
  • 纸巾产品
  • 储存解决方案
  • 免疫抑制剂

6. 2020 年至 2032 年按移植类型分類的全球组织和器官移植市场(十亿美元)

  • 介绍
  • 活体移植
  • 尸体捐赠者移植
  • 自体移植
  • 异种移植
  • 同种异体移植

7. 2020 年至 2032 年全球组织与器官移植市场(按应用划分)(十亿美元)

  • 介绍
  • 器官移植
  • 组织移植

8. 2020 年至 2032 年全球组织和器官移植市场(按最终用户划分)(十亿美元)

  • 介绍
  • 医院
  • 移植中心
  • 组织函式库
  • 其他的

9. 2020 年至 2032 年全球组织与器官移植市场(按地区划分)(十亿美元)

  • 介绍
  • 北美洲
  • 拉丁美洲
  • 欧洲
  • 亚太地区
  • 中东
  • 非洲

第十章 竞争格局

  • 公司简介
    • BD(Becton, Dickinson and Company)
    • LabWare
    • Zimmer Biomet Holdings Inc.
    • Novartis AG
    • Pfizer Inc.
    • Sanofi
    • Medtronic PLC
    • Abbott
    • OrganOX Limited
    • Terumo Corporation
    • TransMedics Inc.
    • BioLife Solutions Inc.
    • Teva Pharmaceuticals
    • F. Hoffmann-La Roche Ltd.
    • Stryker Corporation
    • CryoLife Inc.
    • Abbvie, Inc.
    • Arthrex, Inc.

第 11 章 分析师建议

  • 兴衰
  • 一致的机会地图

第 12 章参考文献与调查方法

  • 参考
  • 调查方法
简介目录
Product Code: CMI4342

Global Tissue And Organ Transplantation Market is estimated to be valued at USD 18.75 Bn in 2025 and is expected to reach USD 35.65 Bn by 2032, growing at a compound annual growth rate (CAGR) of 9.6% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 18.75 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 9.60% 2032 Value Projection: USD 35.65 Bn
Figure. Tissue And Organ Transplantation Market Share (%), By Region 2025
Tissue and Organ Transplantation Market - IMG1

Tissue and organ transplantation refers to the surgical procedure of transferring tissues or organs from one person to another person to repair, replace or enhance the function of the recipient's organ or tissue. The transplantation of tissues and organs has become one of the most rapidly growing specialty areas of medicine in the world. Tissue and organ failure profoundly impact people's lives, however transplantation offers hope for millions of patients worldwide. Growing rates of organ failure due to lifestyle diseases and road accidents have boosted demand for tissue and organ transplantation globally. Advancements in transplantation techniques and immunosuppressive therapies that prevent rejection of transplants can also drive the market growth.

Market Dynamics:

Global tissue and organ transplantation market growth is primarily driven by rising prevalence of chronic diseases and lifestyle disorders resulting in organ failure. Growing geriatric population worldwide is also boosts demand for replacement tissues and organs. According to WHO, the number of people aged 65 years and older is projected to increase from 524 million in 2010 to nearly 1.5 billion in 2050. Furthermore, technological advancements in transplant procedures and development of more effective immunosuppressant drugs to prevent organ rejection can offer new opportunities for market players. However, high costs associated with tissue and organ transplantation surgeries and shortage of matching organs can hamper the market growth. Ethical concerns over organ trafficking and religious prohibitions on organ donations can hamper the supply of transplantable organs.

Key Features of the Study:

  • This report provides in-depth analysis of the global tissue and organ transplantation market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global tissue and organ transplantation market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Zimmer Biomet, Medtronic PLC, Novartis AG, Stryker Corporation, 21st Century Medicine, BiolifeSolutions, CryoLife, Lonza Group
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global tissue and organ transplantation market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global tissue and organ transplantation market

Detailed Segmentation-

  • By Product Type
    • Tissue Products
    • Preservation Solution
    • Immunosuppressive Drugs
  • By Type of Transplant
    • Living Donor Transplant
    • Deceased Donor Transplant
    • Autograft Transplant
    • Xenograft Transplant
    • Allograft Transplant
  • By Application
    • Organ Transplantation
    • Tissue Transplantation
  • By End User
    • Hospital
    • Transplant Centers
    • Tissue Banks
    • Others
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • BD (Becton, Dickinson and Company)
    • LabWare
    • Zimmer Biomet Holdings Inc.
    • Novartis AG
    • Pfizer Inc.
    • Sanofi
    • Medtronic PLC
    • Abbott
    • OrganOX Limited
    • Terumo Corporation
    • TransMedics Inc.
    • BioLife Solutions Inc.
    • Teva Pharmaceuticals
    • Hoffmann-La Roche Ltd.
    • Stryker Corporation
    • CryoLife Inc.
    • Abbvie, Inc
    • Arthrex, Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Product Type
    • Market Snapshot, By Type of Transplant
    • Market Snapshot, By Application
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • Acquisitions and Partnerships Scenario
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Tissue and Organ Transplantation Market - Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the Market

5. Global Tissue and Organ Transplantation Market, By Product Type, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Tissue Products
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Preservation Solution
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Immunosuppressive Drugs
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Tissue and Organ Transplantation Market, By Type of Transplant, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Living Donor Transplant
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Deceased Donor Transplant
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Autograft Transplant
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Xenograft Transplant
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Allograft Transplant
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Tissue and Organ Transplantation Market, By Application, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Organ Transplantation
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Tissue Transplantation
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Tissue and Organ Transplantation Market, By End User, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Hospital
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Transplant Centers
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Tissue Banks
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Tissue and Organ Transplantation Market, By Region, 2020 - 2032, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Region, 2020-2032
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Transplant, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Transplant, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Transplant, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Transplant, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Transplant, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Transplant, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
      • North Africa
      • Central Africa
      • South Africa

10. Competitive Landscape

  • Company Profiles
    • BD (Becton, Dickinson and Company)
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • LabWare
    • Zimmer Biomet Holdings Inc.
    • Novartis AG
    • Pfizer Inc.
    • Sanofi
    • Medtronic PLC
    • Abbott
    • OrganOX Limited
    • Terumo Corporation
    • TransMedics Inc.
    • BioLife Solutions Inc.
    • Teva Pharmaceuticals
    • F. Hoffmann-La Roche Ltd.
    • Stryker Corporation
    • CryoLife Inc.
    • Abbvie, Inc.
    • Arthrex, Inc.

11. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

12. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact